FDA Makes Official MethylGene’s Partial Clinical Hold On ‘0103 Trials
This article was originally published in The Pink Sheet Daily
Executive Summary
With partner Celgene, the firm had already suspended enrollment in Phase I and Phase II trials due to cases of pericarditis.